United states lipid panel testing market opportunities, 2010 2020 brochure

India Adhesives Market Forecast & Opportunities , 2020

United States Lipid Panel Testing Market Opportunities , 2020

P h a r m a & H e a l t h c a r e C o n s u l t a n t s

2

R e s e a r c h M e t h o d o l o g y

Primary Research

•Identifying Key Opinion Leaders

•Questionnaire Design

•In-depth Interviews

•Coverage across Value Chain market

Market Estimation & Forecasting

Bottom-Up or Top-down approach for Market size estimation.

Historical trend examination.

Impact analysis of drivers and challenges to market growth.

Statistical evaluation to develop the actual forecast.

Data Validation, Analysis and Interpretation

Data validation through Primary & Secondary outreach, data analysis and interpretation of key findings

Preliminary Data Mining

Qualitative and Quantitative research

CAGR (2015E-2020F): X%

US Lipid Panel Testing Market Opportunities, 2020

Secondary Research

•Government websites

•Company annual reports, white papers, investor presentations and financial reports

2015E 2016F 2017F 2018F 2019F 2020F© Pharmaion

3

© Pharmaion

S. No. Contents

1. Lipid Panel Testing Overview

2. Research Methodology

3. Analyst View

4. Global Lipid Panel Testing Market Overview

5. United States Lipid Panel Testing Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Type

5.2.3. By End User

5.2.2. By Region

6. United Sates Lipid Panel Testing Service Market Outlook


6.1.1. By Value


6.2.1. By Type

6.2.2. By Service Provider

6.2.3 By Company

7. United Sates Lipid Panel Testing Device Market Outlook


7.1.1. By Value

T a b l e o f C o n t e n t s

S. No. Contents


7.2.1. By Type

7.2.2 By End User

8. Market Dynamics

8.1.1 Drivers

8.1.2. Challenges

9. Market Trends & Developments

9.1. Online Blood Labs

9.2. Non invasive Cholesterol Testing

9.3 Inexpensive Lipid Panel Test

9.4 Mobile based SmartCARD Technology

9.5 Home Based Testing device

10. Policy & Regulatory Landscape

11. United States Economic Profile

12. Competitive Landscape

12.1. Competition Benchmarking (Market Attractiveness)

12.2. Company Profiles

12.2.1. Quest Diagnostics, Inc.

12.2.2 Alere Inc.

12.3.3 Polymer Technology Systems, Inc.

12.4.4 Roche Diagnostics Corporation

12.5.5 Siemens Healthcare Diagnostics, Inc.


3

© Pharmaion

S. No. Contents

12.2.6. Laboratory Corporation of America

12.2.7. Ortho-Clinical Diagnostics, Inc.

12.2.8. Abbott Laboratories

12.2.9. Danaher Corporation

12.2.10. Atherotech, Inc.

13. Strategic Recommendations

14. About Us & Disclaimer


4

© Pharmaion

I n d u s t r y B r i e f

6

© Pharmaion

United States Lipid Panel Testing Market to Cross US$ 6 billion by 2019

Growing consumer awareness coupled with increasing prevalence of cholesterol related diseases to drive UnitedStates lipid panel testing market through 2020

According to recently published Pharmaion report,“United States Lipid Panel Testing Market Opportunities, 2010- 2020”, the lipid panel test market in the United States is anticipated to cross the US$ 6 billion mark by 2019. Awide array of factors anticipated to influence the growth of lipid panel testing market in the US during forecastperiod include high incidence rate of cardiovascular diseases, growing aging population, rising prevalence ofchronic diseases and favorable reimbursement policies. Moreover, increasing automation in laboratories leading tohigher sensitivity and faster test results is forecast to further fuel the market of lipid panel testing in the UnitedStates during 2015 - 2020.

On the basis of services offered, the market has been segmented into two broad categories, namely, Lipid PanelTesting Services and Lipid Panel Testing Devices. Among these categories, lipid panel testing services segmentdominated the United States lipid panel testing market in 2014. The segment is anticipated to continue itsdominance during forecast period as well on account of the implementation of Affordable Care Act, in 2010.Under this act, cholesterol screenings and treatments were made mandatory for all the citizens of the UnitedStates. The largest market share in the United States lipid panel testing market was captured by the country’sSouth region, followed by the West, Midwest and Northeast regions.

“Growing number of initiatives by the government and non-government organizations is resulting in increasingawareness about cardiovascular diseases. In 2011, Centres for Disease Control and Prevention (CDC) launched aninitiative named as “The Million Hearts” with an aim to prevent 1 million heart attacks and strokes by 2017. In2015, an awareness steering committee was set up by The National Forum for Heart Disease & Stroke Prevention,a non-profit organization, which is involved in spreading awareness regarding cholesterol related diseases acrossthe US. All these factors are expected to have a positive impact on the country’s lipid panel testing market through2020.” said Mr. Karan Chechi, Research Director, with Pharmaion Consultants, a research based globalpharmaceutical and healthcare consulting firm.

http://www.pharmaion.com/report/united-states-lipid-panel-testing-market-opportunities-2010--2020/22.html

L i p i d P a n e l T e s t i n g O v e r v i e w

Lipids are defined as a group of fats or fat-like substance which are an important constituents of cells and

sources of energy. The monitoring and maintenance of appropriate levels of these lipids is essential to live a

healthy life.

Lipid Panel Testing (LPT) is the diagnostic method used for analysis of cholesterol level in the person’s blood. It is

majorly recommended by the doctor as a part of risk assessment to determine the possibility of heart diseases in

an individual. The results of these tests plays an important role in deciding the treatment depending upon the

cholesterol levels are at high risk or are at borderline.

TestAcceptable (mg/dL)

Borderline(mg/dL)

High (mg/dL)

Children and Adolescents

XXXX XXXX XXXX XXXX

XXXX XXXX XXXX XXXX

Young AdultsXXXX XXXX XXXX XXXX

XXXX XXXX XXXX XXXX

Table 1: United States Government Recommended Cut-off Levels for Cholesterol Testing

7

© Pharmaion

S a m p l e D a t a - S n a p s h o t

1 2 3 4 57 8 9 10 11 12

2010 2011 2012 2013 2014 2015E2016F2017F2018F2019F2020F

United States Lipid Panel Testing Market

Size, By Value, 2010-2020F (USD Billion)

9

© Pharmaion

8.00% 8.10% 8.20% 8.30% 8.40% 8.50% 8.60% 8.70% 8.80% 8.90% 9.00%

28.00%28.10%28.20%28.30%28.40%28.50%28.60%28.70%28.80%28.90%29.00%

58.00%58.10%58.20%58.30%58.40%58.50%58.60%58.70%58.80%58.90%59.00%

2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

Hospitals

IndependentLabs

POLs &Others

United States Lipid Panel Test Market Share, By End User/Provider, By Value, 2010-2020F

United States Lipid Panel Testing Market Size, By

Region, By Value, 2010-2014 (USD Billion)

1.002.00

3.004.00

5.00

2010 2011 2012 2013 2014

Northeast Region

1.002.00

3.004.00

5.00

2010 2011 2012 2013 2014

West Region

1.002.00

3.004.00

5.00

2010 2011 2012 2013 2014

Midwest Region

1.002.00

3.004.00

5.00

2010 2011 2012 2013 2014

South Region

30.00%30.10%30.20%30.30%30.40%30.50%30.60%30.70%30.80%30.90%31.00%

20.00%20.10%20.20%20.30%20.40%20.50%20.60%20.70%20.80%20.90%21.00%

20.00%20.10%20.20%20.30%20.40%20.50%20.60%20.70%20.80%20.90%21.00%

18.00%18.10%18.20%18.30%18.40%18.50%18.60%18.70%18.80%18.90%19.00%Northeast

Midwest

West

South

United States Lipid Panel Testing Market Size, By

Region, By Value, 2010-2020 (USD Billion)

Shareholder Promoting & Promoting

Groups, 33.00%

Non-Institutions, 33.00%

Public Share Holding, 34.00%

OWNERSHIP STRUCTURE, 2015

Institutional

Ownershi…

Others, 50.00%

OWNERSHIP STRUCTURE (2015)

9

R e p o r t O r d e r i n g

License Type Price

Single User License $2500

Single User License Print $3000

Enterprise License $5000

To View Sample OR Purchase Report

Report Price

Report Name: United States Lipid Panel Testing Market

Opportunities, 2010 – 2020

© Pharmaion



© Pharmaion

10

A b o u t U s & D i s c l a i m e r

NORTH AMERICA

Pharmaion Consultants LLC

708 3RD Avenue, 6th Floor, New York, NY,

United State, 10017

[email protected]

+1 646 360 1656

www.pharmaion.com

About Us

Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.

Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customerswith high value market research and advisory services that helps them identify new market opportunities, growth engines andinnovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market trends. Not bound bylegacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology asengines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaion’s reportsdo not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.

Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them withcomprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trainedindustry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consultingrequirements.

Related Reports

India Stem Cell Market Opportunities, 2010-2020

Global Tissue Engineered Medical Devices Market Opportunities, 2010-2020

Global Cervical Cancer Vaccine Market Opportunities, 2010-2020

DisclaimerThe contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is madethat it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained fromvarious sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy orcompleteness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information andespecially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimatesand forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’sinternal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants.

ASIA PACIFIC

Pharmaion Consultants Pvt. Ltd.

A – 51, Sector 57, Noida, National Capital Region,

India - 201301

[email protected]

+91 - 120 - 452 3900

www.pharmaion.com